ASX:PMEHealthcare Services
Assessing Pro Medicus’s Valuation After New US Contracts And Visage 7 Product Updates
Pro Medicus (ASX:PME) is back in focus after securing about A$40 million in US contract renewals, including an expanded MedStar Health deal covering cardiology imaging and a higher fee renewal with Zwanger-Pesiri.
See our latest analysis for Pro Medicus.
These contract wins and product updates come after a tough share price stretch, with a 30 day share price return of 21.52% decline and a year to date share price return of 40.26% decline. However, the 3 year total shareholder return is...